Copaiba is the oleoresin (OR) obtained from Copaifera (Fabaceae), a neotropical tree which grows in Amazon regions. The balsam, constituted by an essential oil and a resinous fraction is used as folkloristic remedy in the treatment of several inflammatory diseases and for its antioxidant and antibacterial properties. Aim of this work was (a) to carry out a characterization by GC-MS of the volatile and nonvolatile constituents of Copaifera langsdorffii Desf. oleoresin (OR); (b) to investigate the mechanism of its anti-inflammatory activity; (c) to evaluate its antipsoriatic effect after oral intake/topical application. The volatile fraction (yield: 22.51%, w/w) shows: alpha-bergamotene (48.38%), alpha-himachalene (11.17%), beta-selinene (5.00%) and beta-caryophyllene (5.47%). The OR residue (77.49%, w/w), after derivatization, showed as main constituents the following compounds: copalic, abietic, daniellic, lambertinic, labd-7-en-15-oic, pimaric, isopimaric acids and kaur16-en18-oic acid. Preincubation of LPS-stimulated human THP-1 monocytes with increasing concentrations of the OR purified fraction (OR-PF), containing diterpene acids, diterpenes and sesquiterpenes, reduced the release of pro-inflammatory cytokines (IL-1 beta, IL-6, TNF alpha) in a dose-range of 0.1-10 mu M. In addition, in cell culture system of human THP-1 monocytes, 1 mu M OR-PF counteracts LPS-driven NF-kappa B nuclear translocation. In a preliminary clinical trial three patients affected by chronic psoriasis, treated with oral intake or topical application of the OR, exhibited a significant improvement of the typical signs of this disease, i.e. erythema, skin thickness, and scaliness. In conclusion, the results of this work, beside an extensive analytical characterization of the OR chemical composition, provide strong evidences that its anti-inflammatory activity is related to the inhibition of the NF-kappa B nuclear translocation, and consequently of proinflammatory cytokines secretion.

GC-MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect / F. Gelmini, G. Beretta, C. Anselmi, M. Centini, P. Magni, M. Ruscica, A. Cavalchini, R. Maffei Facino. - In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. - ISSN 0378-5173. - 440:2(2013 Jan 20), pp. 170-178. [10.1016/j.ijpharm.2012.08.021]

GC-MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect

F. Gelmini
Primo
;
G. Beretta
Secondo
;
P. Magni;M. Ruscica;R. Maffei Facino
Ultimo
2013

Abstract

Copaiba is the oleoresin (OR) obtained from Copaifera (Fabaceae), a neotropical tree which grows in Amazon regions. The balsam, constituted by an essential oil and a resinous fraction is used as folkloristic remedy in the treatment of several inflammatory diseases and for its antioxidant and antibacterial properties. Aim of this work was (a) to carry out a characterization by GC-MS of the volatile and nonvolatile constituents of Copaifera langsdorffii Desf. oleoresin (OR); (b) to investigate the mechanism of its anti-inflammatory activity; (c) to evaluate its antipsoriatic effect after oral intake/topical application. The volatile fraction (yield: 22.51%, w/w) shows: alpha-bergamotene (48.38%), alpha-himachalene (11.17%), beta-selinene (5.00%) and beta-caryophyllene (5.47%). The OR residue (77.49%, w/w), after derivatization, showed as main constituents the following compounds: copalic, abietic, daniellic, lambertinic, labd-7-en-15-oic, pimaric, isopimaric acids and kaur16-en18-oic acid. Preincubation of LPS-stimulated human THP-1 monocytes with increasing concentrations of the OR purified fraction (OR-PF), containing diterpene acids, diterpenes and sesquiterpenes, reduced the release of pro-inflammatory cytokines (IL-1 beta, IL-6, TNF alpha) in a dose-range of 0.1-10 mu M. In addition, in cell culture system of human THP-1 monocytes, 1 mu M OR-PF counteracts LPS-driven NF-kappa B nuclear translocation. In a preliminary clinical trial three patients affected by chronic psoriasis, treated with oral intake or topical application of the OR, exhibited a significant improvement of the typical signs of this disease, i.e. erythema, skin thickness, and scaliness. In conclusion, the results of this work, beside an extensive analytical characterization of the OR chemical composition, provide strong evidences that its anti-inflammatory activity is related to the inhibition of the NF-kappa B nuclear translocation, and consequently of proinflammatory cytokines secretion.
chemical composition; copaifera langsdorffii Desf.; cytokines secretion; diterpenes and diterpene acids; GC-MS analysis; Nf-κB translocation; psoriasis
Settore CHIM/08 - Chimica Farmaceutica
Settore MED/05 - Patologia Clinica
Settore BIO/13 - Biologia Applicata
Settore BIO/09 - Fisiologia
Settore MED/04 - Patologia Generale
Settore MED/46 - Scienze Tecniche di Medicina di Laboratorio
20-gen-2013
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0378517312008162-main.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 624.34 kB
Formato Adobe PDF
624.34 kB Adobe PDF Visualizza/Apri
BerettaGelminiMaffei_InternJournPharmaceu_2012.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 946.42 kB
Formato Adobe PDF
946.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/204378
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 84
  • ???jsp.display-item.citation.isi??? 77
social impact